Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SENSEONICS HOLDINGS, INC.

(SENS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Senseonics Holdings, Inc.
Senseonics Holdings, Inc. is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes. The Company's Eversense system consists of components, such as a sensor, which is inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user's mobile device, such as a smartphone, Apple Watch or tablet.

Number of employees : 82 people.
Sales per Business
20192020Delta
Glucose Monitoring Products21.30100%4.95100% -76.77%
USD in Million
Sales per region
20192020Delta
Non-United States18.0584.8%3.8277.2% -78.84%
United States3.2515.2%1.1322.8% -65.26%
USD in Million
Managers
Name Title Age Since
Timothy T. Goodnow, Dr. President, Chief Executive Officer & Director 58 2015
Nick B Tressler Secretary, Chief Financial & Accounting Officer 47 -
Francine R. Kaufman, Dr. Director & Chief Medical Officer 69 2019
Mukul Jain, Dr. Chief Operating Officer 47 2017
Stephen DeFalco Chairman 59 2015
Edward J. Fiorentino Independent Director 61 2015
Douglas S. Prince Independent Director 66 2015
Douglas A. Roeder Independent Director 49 2015
Steven V. Edelman, Dr. Independent Director 64 2016
Anthony R. Raab Independent Director 39 2020
Members of the board
Name Title Age Since
Stephen DeFalco Chairman 59 2015
Edward J. Fiorentino Independent Director 61 2015
Douglas S. Prince Independent Director 66 2015
Douglas A. Roeder Independent Director 49 2015
Timothy T. Goodnow, Dr. President, Chief Executive Officer & Director 58 2015
Steven V. Edelman, Dr. Independent Director 64 2016
Francine R. Kaufman, Dr. Director & Chief Medical Officer 69 2019
Robert Schumm Director 54 2020
Anthony R. Raab Independent Director 39 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 445,254,993 399,010,548 89.6% 0 0.0% 89.6%
Shareholders
NameEquities%
Roche Holding AG 35,046,418 7.87%
Robert L Smith 19,716,139 4.43%
Steward Capital Holdings LP 19,000,000 4.27%
The Vanguard Group, Inc. 15,214,952 3.42%
NEA Management Co. LLC 11,464,235 2.57%
SSgA Funds Management, Inc. 10,271,559 2.31%
Delphi Ventures, Inc. 9,846,294 2.21%
BlackRock Fund Advisors 8,932,752 2.01%
Wellington Management Co. LLP 7,638,529 1.72%
Masters Capital Management LLC 7,000,000 1.57%
Company contact information
Senseonics Holdings, Inc.
20451 Seneca Meadows Parkway
Germantown, MD 20876-7005

Phone : +1.301.515.7260
Fax : +1.301.515.0988
Web : http://www.senseonics.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Senseonics Holdings, Inc.
Sector Other Medical Equipment, Supplies & Distribution
Connections : Senseonics Holdings, Inc.